| 01:38 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 05:26 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 11:18 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 01:41 PM |
Standalone And Consolidated Financial Results For Q3FY26
|
| 01:36 PM |
Board Meeting Outcome for Standalone And Consolidated Financial Results For Q3FY26
|
| 05:09 PM |
Commencement Of Commercial Production At Company''s New Manufacturing Unit Situated At Village Hingani,
District - Wardha
|
| 12:46 PM |
Disclosure pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015
|
| 05:16 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 11:22 AM |
Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December, 2025
|
| 11:21 AM |
Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December, 2025
|
| 03:41 PM |
Re-Lodgement Of Transfer Request Report - November 2025 And December 2025
|
| 10:54 AM |
Sale Of 100% Equity Shares Of Wholly Owned Step-Down Subsidiary And Updation Of Registered Office Address
|
| 10:44 AM |
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
|
| 10:40 AM |
Board Meeting Outcome for Outcome Of Board Meeting
|
| 11:44 AM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 10:18 AM |
Closure of Trading Window
|
| 02:30 PM |
Inspection Of Company'S Active Pharmaceutical Ingredients (Apis) Manufacturing Facility Situated At Tarapur (Palghar-Maharashtra) By US FDA
|
| 03:46 PM |
Re-Lodgement Of Transfer Requests Of Physical Shares Report - October 2025
|
| 02:09 PM |
Clarification Sought On Volume Movement
|
| 01:55 PM |
Clarification sought from Ipca Laboratories Ltd
|
| 01:04 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 03:10 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:03 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 01:45 PM |
Standalone And Consolidated Q2-H1 FY26 Results And Press Release
|
| 01:40 PM |
Board Meeting Outcome for Standalone And Consolidated Q2-H1 FY26 Results And Press Release
|
| 10:09 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 12:46 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 05:27 PM |
Slump Sale Of Company''s Apis And Drug Intermediates Manufacturing Unit Situated At Ankleshwar
|
| 05:27 PM |
Slump Sale Of Company''s Apis And Drug Intermediates Manufacturing Unit Situated At Ankleshwar
|
| 05:24 PM |
Board Meeting Outcome for Outcome Of Board Meeting
|
| 03:45 PM |
Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30.09.2025
|
| 10:47 AM |
Incorporation Of A Wholly Owned Subsidiary In Germany
|
| 05:14 PM |
Re-Lodgment Of Transfer Requests For Physical Shares - Sep 2025
|
| 12:48 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:56 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 01:19 PM |
Closure of Trading Window
|
| 05:42 PM |
Relodgement Of Transfer Request For Physical Shares
|
| 03:56 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 12:44 PM |
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
|
| 04:17 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 05:18 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 12:59 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 11:44 AM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 05:47 PM |
Shareholder Meeting / Postal Ballot-Outcome of AGM
|
| 01:50 PM |
Financial Results
|
| 01:35 PM |
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results
|
| 05:17 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 03:36 PM |
Board Meeting Intimation for Standalone And Consolidated Results For Q1FY26
|
| 11:08 AM |
Intimation To Shareholder'S Whose E-Mail Addresses Are Not Registered With The Company/Depository
Participants/Registrar And Share Transfer Agent
|
| 11:06 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 03:37 PM |
Record Date For Members Entitlement Of Final Dividend
|
| 03:34 PM |
75Th Annual General Meeting Of The Company To Be Held On Monday, 11Th August, 2025 At 3.30 P.M.
|
| 01:22 PM |
Business Responsibility and Sustainability Reporting (BRSR)
|
| 09:24 AM |
Reg. 34 (1) Annual Report.
|
| 11:09 AM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 06:23 PM |
Announcement under Regulation 30 (LODR)-Credit Rating
|
| 04:53 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:03 PM |
Order Received Under Central Goods And Service Tax Act, 2017
|
| 09:29 AM |
Closure of Trading Window
|
| 05:04 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 12:17 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 11:52 AM |
Change In The Name Of Statutory Audit Firm
|
| 03:03 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:26 PM |
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
|
| 05:15 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 03:28 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 07:36 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 09:46 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 02:18 PM |
Board Meeting Intimation for Standalone & Consolidated Audited Financial Results For The 4Th Quarter And FY25 And Recommendation Of Final Dividend For FY 24-25
|
| 10:19 AM |
General Updates - Unichem Laboratories Ltd., Ireland
|
| 11:14 AM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 12:40 PM |
Slump Sale Of Manufacturing Unit And Acquisition
|
| 12:37 PM |
Announcement under Regulation 30 (LODR)-Acquisition
|
| 12:34 PM |
Board Meeting Outcome for Outcome Of Board Meeting
|
| 03:31 PM |
Closure of Trading Window
|
| 03:48 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 12:38 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 03:56 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:35 PM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
|
| 01:15 PM |
Integrated Filing (Financial)
|
| 01:07 PM |
Standalone And Consolidated Q3FY25 Results
|
| 01:04 PM |
Board Meeting Outcome for Standalone And Consolidated Q3FY25 Results & Press Release
|
| 11:08 AM |
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
|
| 03:16 PM |
Order Received Under CGST Act
|
| 05:16 PM |
Order Received Under Central Goods And Service Tax Act, 2017
|
| 05:51 PM |
Orders Received Under CGST Act
|
| 10:03 AM |
Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For Q3 And Nine Months Ended 31St December, 2024
|